Dr Jitendra Singh at the inaugural ceremony of RSSDI 2026 in BengaluruUnion Minister Dr Jitendra Singh at the inaugural ceremony of RSSDI 2026 in Bengaluru, 20 November 2026. Photo: PIB

Bengaluru, November 20: More than a dozen diabetes-related research projects are under way under the Ministry of Science and Technology, mostly through the Department of Biotechnology (DBT) and some through CSIR, Union Minister Dr Jitendra Singh said on Friday. He also urged doctors and scientists to counter misinformation on diet and the unprescribed use of weight-loss drugs.

Dr Singh was speaking at the inaugural ceremony of RSSDI 2026, the conference of diabetologists, clinicians and researchers being held in Bengaluru from November 19 to 22. Karnataka minister Krishna Byre Gowda and MP Dr C. N. Manjunath were also present.

Research projects named

Dr Singh said the research increasingly focuses on preventing and controlling diabetes through molecular and genetic approaches. The projects he listed include:

  • an Indo-Danish study of India-specific changes in gut microbiota among prediabetic and diabetic patients
  • a DBT-supported study on genetically engineered E. coli Nissle 1917 that produces GLP-1, which could be developed as a probiotic way of delivering the molecule through the gut, with human studies expected
  • work at BRIC-THSTI on expressing GLP-1 analogues in gut bacteria
  • research on interventions from before conception to early childhood to reduce cardiometabolic risk, and the EINSTEIN study in rural Mysuru
  • biomarkers to predict Type 2 diabetes in women with a history of gestational diabetes
  • studies on the link between Type 2 diabetes and fatty liver disease, including a possible neutralising monoclonal antibody
  • efforts towards temperature-resilient insulin, and startup research on oral insulin

He also mentioned research on macrophage Gi signalling as a possible target for treating obesity and Type 2 diabetes, published in the Journal of Clinical Investigation in September 2026, and Indian biosimilars of liraglutide and insulin Lispro.

Warning on misinformation

The minister cautioned against diet advice from self-styled nutritionists, unscientific claims and the use of obesity drugs without a prescription. He said misinformation can do more harm than a lack of information, and asked credible scientific voices to engage with the public.

With nearly 70 per cent of India’s population below the age of 40, he said preventing obesity and diabetes among young people was a national responsibility and could not be left to diabetologists alone.

Dr Singh referred to the India Genome Study of 10,000 people across 84 population groups and said the country’s genetic diversity could help advance precision medicine. He called for more collaboration between government institutions, private researchers, clinicians, startups and medical associations.

Related: IISF 2026 to be held in Pune from December 19 to 22

Leave a Reply

Your email address will not be published. Required fields are marked *